Orca1

FDA inspection

Denison Pharmaceuticals, LLC: FDA inspection ending Apr 27, 2001

FDA inspection 70545 · Voluntary Action Indicated (VAI) · Lincoln, RI

Key facts

Inspection ID 70545
Firm Denison Pharmaceuticals, LLC
FEI number 1210580
Address 1 Powder Hill Rd
City Lincoln
State RI
ZIP 02865-4407
Fiscal year 2001
Inspection end date Apr 27, 2001
Classification Voluntary Action Indicated (VAI)
Project area Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation|Drug Quality Assurance|New Drug Evaluation
Product type Drugs, Food/Cosmetics

At a glance

  • 1–9 Citations
  • 1–9 Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • No Establishment inspection report (EIR) exists
  • 10–99 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

Other inspections at this establishment

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections